These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [A contribution on the problem of hydrogen peroxide ointment]. Wächter HJ Pharm Prax; 1968; 8():200-1. PubMed ID: 5711297 [No Abstract] [Full Text] [Related]
5. [Design of mathematical models of ointment extensibility]. del Pozo Carrascosa A; Suñé Negre JM; Faulí Trillo C Boll Chim Farm; 1987 Aug; 126(8):330-5. PubMed ID: 3451750 [No Abstract] [Full Text] [Related]
6. A study of the diffusion of two soluble sulfonamides from ointment bases. Whitworth CW; Becker CH Am J Hosp Pharm; 1966 Oct; 23(10):574-7. PubMed ID: 5915780 [No Abstract] [Full Text] [Related]
7. The "bubble point" for validation of drug release or simulated absorption tests for ointments. Realdon N; Tagliaboschi A; Perin F; Ragazzi E Pharmazie; 2005 Dec; 60(12):910-6. PubMed ID: 16398267 [TBL] [Abstract][Full Text] [Related]
8. [Influence of the size of salicylic acid particles on their diffusion from some ointment bases]. Kucera J; Veber V Cesk Dermatol; 1966 Aug; 41(4):229-30. PubMed ID: 5975159 [No Abstract] [Full Text] [Related]
9. A comparison of topical formulations for the prevention of human schistosomiasis. Cooper E; Iqbal A; Bartlett A; Marriott C; Whitfield PJ; Brown MB J Pharm Pharmacol; 2004 Aug; 56(8):957-62. PubMed ID: 15285838 [TBL] [Abstract][Full Text] [Related]
11. [Stability of anhydrous and hydrated ointment bases containing solid soy bean oil]. Wiśniewski W; Golucki Z Acta Pol Pharm; 1966; 23(3):235-8. PubMed ID: 5950199 [No Abstract] [Full Text] [Related]
12. [Contributions to the liberation of drugs from suspension ointments. Part 19: Studies on the interactions of hydroxyquinoline (salts) with ointment components (author's transl)]. Heber B; Horsch W Pharmazie; 1982 Apr; 37(4):277-9. PubMed ID: 7100252 [TBL] [Abstract][Full Text] [Related]
13. [State of order, properties and dynamics of structure in shear-crystallized ointments (author's transl)]. Hüttenrauch R; Fricke S; Baumann V Pharmazie; 1982 Jan; 37(1):25-8. PubMed ID: 7071108 [TBL] [Abstract][Full Text] [Related]
14. [The stabilization of urea and prednisolone in a L/W emulsion ointment]. Horsch W; Mende W; Wolf B; Finke I Pharmazie; 1984 Jul; 39(7):503-4. PubMed ID: 6494230 [No Abstract] [Full Text] [Related]
15. [The dynamics of the drug release from ointment bases. Part 5: The effects of tensides on the liberation of atropine from eye ointments (author's transl)]. Pasich J; Bether W; Malaga M Pharmazie; 1981 Apr; 36(4):267-9. PubMed ID: 7255527 [TBL] [Abstract][Full Text] [Related]
16. Selection and effect of ointment bases for preparing collagenase inhibitor ointment using high-performance liquid chromatography and Franz cell apparatus. Nishizawa S; Yamaoka H; Matsui M; Hirabayashi S; Hoshi K; Koshima I; Yamaoka K Ann Plast Surg; 2009 Feb; 62(2):187-93. PubMed ID: 19158532 [TBL] [Abstract][Full Text] [Related]
17. Use of repellents as prophylactic agents. Nentwig G Parasitol Res; 2003 Jun; 90 Supp 1():S40-8. PubMed ID: 12811547 [TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical availability of clobetasol-17-propionate from cream and ointment. Dyderski S; Grześkowiak E; Szałek E; Mrzygłód A Acta Pol Pharm; 2001; 58(6):435-8. PubMed ID: 12197615 [TBL] [Abstract][Full Text] [Related]
19. Influence of particle size on the quantitative determination of salicylic acid in a pharmaceutical ointment using FT-Raman spectroscopy. De Beer TR; Baeyens WR; Heyden YV; Remon JP; Vervaet C; Verpoort F Eur J Pharm Sci; 2007 Mar; 30(3-4):229-35. PubMed ID: 17161940 [TBL] [Abstract][Full Text] [Related]
20. Viscosity of pharmacopeial multimolecular ointment vehicles and pharmaceutical availability of a model therapeutic agent. Piechota-Urbańska M; Kołodziejska J; Zgoda MM Polim Med; 2007; 37(2):3-19. PubMed ID: 17957945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]